GTR 114596311
Bids Are Invited For Daratumumab 100 Mg - Injectable Solution - 5 Ml Vial And Others
ICB — International Competitive Bid
Closes Jul 21, 2026
— 4 days left
South America
Tender Information
GTR Reference
114596311
Tendering Authority
Subscribe to view
Tender No
439/2026
Financer Name
Self-Funded
Work Title
Bids Are Invited For Daratumumab 100 Mg - Injectable Solution - 5 Ml Vial And Others
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
21-07-2026
4 days left
Work Detail
Daratumumab - Concentration: 20 Mg/Ml; Pharmaceutical Form: Injectable Solution, Trazodone Hydrochloride, Concentration: 150 Mg, Pharmaceutical Form: Controlled Release, Trifluridine, Composition: Associated With Tipiracil, Concentration: 20 Mg + 8, 19 Mg, Timolol - Composition: Associated With Brimonidine And Bimatoprost; Concentration: 0.5% + 0.15% + 0.01%; Pharmaceutical Form: Ophthalmic Solution (Brand: Triplenex)., Vortioxetine, Composition: Hydrobromide Salt, Concentration: 10 Mg, Nintedanib - Composition: Esylate Salt; Concentration: 100 Mg (Brand: Ofev).
Key Value
Tender Value
3,080,078 - BRL
Tender Documents
Global Tender Document
80f9cf32-f160-4e4f-a345-81cac2cd2246.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.